Reuniting the split streams: the Meiji Seika–Meiji Dairies merger (2009)

Closing a sixty-year split — and choosing to keep two legs

The merger reversed a division that history had forced. The three streams Soma Hanji built to internalise his own sugar demand had been torn apart in 1945 by the dissolution of the zaibatsu and the loss of Taiwan, and for six decades Meiji Seika and Meiji Dairies grew as strangers in the same home market. What finally reunited them was not ambition but shared exhaustion: a shrinking, ageing Japan that had stopped growing the sweets and dairy markets, leaving both firms caught between price wars and dear inputs and unable to fix their margins alone. On paper the dairy company was larger, yet the exchange ratio of one to 1.7 and the higher profitability of the confectioner left the two treated as near-equals — folded together under the single “Meiji” brand.

The sharper decision came in 2011. Rather than fuse everything, Meiji split the group into a food company and a drug company — Meiji Co. and Meiji Seika Pharma — deliberately keeping the two unlike legs apart under one brand. That preserved the pharmaceutical arm’s research independence and spared management the awkwardness of housing candy and antibiotics in one ledger. But it also postponed the very question the merger had raised: whether food and medicine truly belong together, or merely share a name and a history. The structure Meiji chose in 2009–2011 answered how to combine two firms, and left open why — a question the group would still be wrestling with a decade and a half later.